Intrauterine administration of prostaglandin 15 (S) 15 methyl E2 methyl ester in the management of patients with a hydatidiform mole.
D000028:Abortion, Induced; D003475:Curettage; D005260:Female; D005334:Fever / Q000139:chemically induced; D005865:Gestational Age; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D012768:Shivering / Q000187:drug effects; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins